Canine Influenza Vaccines | Dog Flu Vaccination Products

product package
  • Nobivac® Canine Flu H3N8 was the first fully licensed canine influenza vaccine by the USDA and has been safely used in over 7 million dogs3
  • Proven to reduce the severity and spread of disease33
  • Administered subcutaneously as an initial dose followed by a booster 2 to 4 weeks later
  • Annual revaccination with one dose is recommended
  • Safe for use in dogs 6 weeks of age or older
  • Recommended for all dogs with exposure to other social dogs (boarding facilities, doggie daycare, agility competitions, dog shows, groomers, shelters, etc)
  • Packaged in a convenient 25 x 1 mL presentation
product package
  • Canine Influenza Vaccine H3N2.
  • Inactivated virus vaccine. Adjuvanted to enhance immune response.
  • 1 ml dose subcutaneously. Booster 2 - 4 weeks later. Annual revaccination with 1 dose recommended
  • Professional Support from Merck Animal Health
  • Recommended for social dogs at risk
  • This vaccine is conditionally licensed and has a reasonable expectation of efficacy and safety.
product package
  • Nobivac Canine Flu Bivalent.
  • Aids in the control of disease associated with Canine Influenza H3N8 and H3N2 infection.
  • Administered subcutaneously as an initial dose, followed by a booster 2 to 4 weeks later.
  • Annual re-vaccination with one dose is recommended
  • Safe to use in dogs 7 weeks of age or older
  • Recommended for all dogs with exposure to other social dogs (Boarding Facilities, Doggie Daycare, Agility Competitions, Dog Shows, Groomers, Shelters, Dogs living in high rise buildings, etc.)